Overview
Onyemaechi Okolo-Taku is a Hematologist Oncology specialist and a Hematologist in Gilbert, Arizona. Dr. Okolo-Taku is rated as an Experienced provider by MediFind in the treatment of Multiple Carboxylase Deficiency. Her top areas of expertise are Childhood Iron Deficiency Anemia, Agranulocytosis, Chronic Familial Neutropenia, and Iron Deficiency Anemia. Dr. Okolo-Taku is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3686 S Rome St, Gilbert, AZ 85297
Honorhealth Ambulatory
John Bibb is an Oncologist and a Hematologist Oncology provider in Phoenix, Arizona. Dr. Bibb is rated as a Distinguished provider by MediFind in the treatment of Multiple Carboxylase Deficiency. His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Hemochromatosis, and Pleuropulmonary Blastoma. Dr. Bibb is currently accepting new patients.
Honorhealth Ambulatory
Robin Obenchain is a Hematologist Oncology specialist and an Oncologist in Scottsdale, Arizona. Dr. Obenchain is rated as a Distinguished provider by MediFind in the treatment of Multiple Carboxylase Deficiency. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Obenchain is currently accepting new patients.
Ironwood Physicians PC
Mikhail Shtivelband is a Hematologist Oncology specialist and a Hematologist in Mesa, Arizona. Dr. Shtivelband is rated as a Distinguished provider by MediFind in the treatment of Multiple Carboxylase Deficiency. His top areas of expertise are Hemochromatosis, Non-Small Cell Lung Cancer (NSCLC), Plasmacytoma, and Lung Cancer. Dr. Shtivelband is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Mountain SicknessDr. Okolo-Taku isAdvanced. Learn about Acute Mountain Sickness.
- AgranulocytosisDr. Okolo-Taku isAdvanced. Learn about Agranulocytosis.
- AnemiaDr. Okolo-Taku isAdvanced. Learn about Anemia.
- Blood ClotsDr. Okolo-Taku isAdvanced. Learn about Blood Clots.
- Breast CancerDr. Okolo-Taku isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Okolo-Taku isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Okolo-Taku isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Acute Hepatic Porphyria (AHP)Dr. Okolo-Taku isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Adenoid Cystic CarcinomaDr. Okolo-Taku isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Immune ThrombocytopeniaDr. Okolo-Taku isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Okolo-Taku isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Okolo-Taku isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.